Status:
COMPLETED
Effect of Fermented Soybean (FSB) Supplementation on Gas-troesophageal Reflux Disease (GERD)
Lead Sponsor:
NATTOME SDN BHD
Collaborating Sponsors:
UCSI University
Conditions:
Gastro Esophageal Reflux
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Gastroesophageal reflux disease (GERD) is a prevalent chronic condition affecting the well-being of both adults and children in general medical practice. Research on the effects of fermented soy-bean ...
Eligibility Criteria
Inclusion
- (1) experienced heartburn, acid reflux, regurgitation, or non-cardiac chest pain within the past three months; (2) aged 18 years or older; (3) demonstrated the ability to comprehend the study protocol and information provided by the investigators; and (4) provided in-formed consent.
Exclusion
- 1\) use of medications related to GERD, such as acid inhibitors, antacids, prokinetics, gastric mucosal protectors, herbs, probiotics, or related preparations within the past two weeks; (2) a history of gastro-esophageal or duodenal surgery; (3) diagnosis of peptic ulcer, gastrointestinal bleeding, esophageal or gastric varices, or upper GI malignancies confirmed by endoscopy at tertiary hospitals; and (4) pregnancy or lactation
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06524271
Start Date
November 1 2023
End Date
May 31 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSI University
Cheras, Kuala Lumpur, Malaysia, 56000